Articles from Biotech Business (November 1, 2003)

Title	Author	Type	Words
BIORAL DELIVERY IMPROVES EFFICACY/REDUCES ASPIRIN SIDE EFFECTS.			349
EUROPEAN APPROVAL OF REMODULIN DELAYED.			165
IDUN GETS ORPHAN DRUG DESIGNATION IN ORGAN TRANSPLANTATION.			503
NICOX TO REACQUIRE RIGHTS TO ASTRAZENICA CINOD CLASS OF DRUGS.			268
NUVELO ASSIGNS PATENTS TO SEQUENOM.			431
RXPEDITE TO MANAGE COMMERCIALIZATION OF FAMPRIDINE-SR.			461
SCICLONE ENROLLS 500 PATIENTS IN FIRST OF HEPATITIS C TRIALS.			700